» Articles » PMID: 29569077

Protective Effect of Quercetin in LPS-Induced Murine Acute Lung Injury Mediated by CAMP-Epac Pathway

Overview
Journal Inflammation
Date 2018 Mar 24
PMID 29569077
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Quercetin (Que) as an abundant flavonol element possesses potent antioxidative properties and has protective effect in lipopolysaccharide (LPS)-induced acute lung injury (ALI), but the specific mechanism is still unclear, so we investigated the effect of Que from in vivo and in vitro studies and the related mechanism of cAMP-PKA/Epac pathway. The results in mice suggested that Que can inhibit the release of inflammatory cytokine, block neutrophil recruitment, and decrease the albumin leakage in dose-dependent manners. At the same time, Que can increase the cAMP content of lung tissue, and Epac content, except PKA. The results in epithelial cell (MLE-12) suggested that Que also can inhibit the inflammatory mediators keratinocyte-derived chemokines release after LPS stimulation; Epac inhibitor ESI-09 functionally antagonizes the inhibitory effect of Que; meanwhile, PKA inhibitor H89 functionally enhances the inhibitory effect of Que. Overexpression of Epac1 in MLE-12 suggested that Epac1 enhance the effect of Que. All those results suggested that the protective effect of quercetin in ALI is involved in cAMP-Epac pathway.

Citing Articles

PDE4B Modulates Phosphorylation of p65 (Ser468) via cAMP/PKA in Acute Lung Injury.

Dhar R, Li Y, Hu Z, Song S, Zhang Z, Ji J Lung. 2025; 203(1):33.

PMID: 39956855 DOI: 10.1007/s00408-025-00787-6.


Quercetin: A Flavonoid with Potential for Treating Acute Lung Injury.

Huang M, Liu X, Ren Y, Huang Q, Shi Y, Yuan P Drug Des Devel Ther. 2024; 18():5709-5728.

PMID: 39659949 PMC: 11630707. DOI: 10.2147/DDDT.S499037.


Quercetin as a therapeutic agent activate the Nrf2/Keap1 pathway to alleviate lung ischemia-reperfusion injury.

Yousefi Zardak M, Keshavarz F, Mahyaei A, Gholami M, Moosavi F, Abbasloo E Sci Rep. 2024; 14(1):23074.

PMID: 39367100 PMC: 11452703. DOI: 10.1038/s41598-024-73075-7.


Protective mechanism of quercetin in alleviating sepsis-related acute respiratory distress syndrome based on network pharmacology and experiments.

Ding W, Zhang W, Chen J, Wang M, Ren Y, Feng J World J Emerg Med. 2024; 15(2):111-120.

PMID: 38476533 PMC: 10925531. DOI: 10.5847/wjem.j.1920-8642.2024.030.


Discovery of the Active Compounds of the Ethyl Acetate Extract Site of (Thunb.) Blume for the Treatment of Acute Lung Injury.

Sun S, Liu X, Zhao D, Zheng L, Han X, Tian Y Molecules. 2024; 29(4).

PMID: 38398522 PMC: 10891587. DOI: 10.3390/molecules29040770.


References
1.
Wu S, Chiang H, Shen A, Lo Y . Differential effects of quercetin, a natural polyphenolic flavonoid, on L-type calcium current in pituitary tumor (GH3) cells and neuronal NG108-15 cells. J Cell Physiol. 2003; 195(2):298-308. DOI: 10.1002/jcp.10244. View

2.
Wang Y, Zhang W, Lv Q, Zhang J, Zhu D . The critical role of quercetin in autophagy and apoptosis in HeLa cells. Tumour Biol. 2015; 37(1):925-9. DOI: 10.1007/s13277-015-3890-4. View

3.
Yilmaz M, Guzel A, Caglar Torun A, Okuyucu A, Salis O, Karli R . The therapeutic effects of anti-oxidant and anti-inflammatory drug quercetin on aspiration-induced lung injury in rats. J Mol Histol. 2013; 45(2):195-203. DOI: 10.1007/s10735-013-9542-3. View

4.
Hastie A, Wu M, Foster G, Hawkins G, Batra V, Rybinski K . Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and beta2-agonist use. Respir Res. 2006; 7:25. PMC: 1388207. DOI: 10.1186/1465-9921-7-25. View

5.
Zhu Y, Chen H, Boulton S, Mei F, Ye N, Melacini G . Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 "therapeutic window". Sci Rep. 2015; 5:9344. PMC: 4366844. DOI: 10.1038/srep09344. View